Braveheart Bio Readies $300 Million IPO Plan (Pending:BRVE)
· seekingalpha.com
Braveheart Bio’s $300M BRVE IPO aims to advance BHB-1893 for HCM after strong Phase 2 results.
Donovan Jones is an IPO research specialist with 15 years of experience analyzing investment opportunities for U.S. IPOs.He also leads the investing group IPO E...